Return to content in this issue


Use of Concentrated Plasma-Derived Subcutaneous C1 Inhibitor as Long-Term Prophylaxis in an 8-Year- Old Child With Hereditary Angioedema

Lasa EM1, Herrero L2, Martínez S1, Arruti N1, Oliver P2, Joral A1

1Hospital Universitario de Donostia, San Sebastián, Spain
2Hospital de Mendaro, Mendaro, Spain

J Investig Allergol Clin Immunol 2023; Vol 33(4) : 302-304
doi: 10.18176/jiaci.0855

Key words: C1 inhibitor deficiency, Hereditary angioedema, Children, Long-term treatment, Management